Millipore Sigma Vibrant Logo
Atención: Nos hemos mudado. Los productos Merck Millipore ya no pueden adquirirse en MerckMillipore.comMás información

AB5388 Anti-Synphilin-1 Antibody, a.a. 829-847

AB5388
50 µL  
Purchase on Sigma-Aldrich

Ofertas especiales

Descripción

Replacement Information

Ofertas especiales

Tabla espec. clave

Species ReactivityKey ApplicationsHostFormatAntibody Type
H, RIHCRbSerumPolyclonal Antibody
Description
Catalogue NumberAB5388
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionAnti-Synphilin-1 Antibody, a.a. 829-847
Alternate Names
  • Alpha-Synuclein Interacting Protein
References
Product Information
FormatSerum
PresentationRabbit serum. Lyophilized. Contains no preservative. Reconstitute with 50 μL of sterile distilled water. Centrifuge if necessary to remove any residue.
Quality LevelMQ100
Applications
ApplicationAnti-Synphilin-1 Antibody, a.a. 829-847 detects level of Synphilin-1 & has been published & validated for use in IH.
Key Applications
  • Immunohistochemistry
Application NotesImmunohistochemistry: 1:1,000-1:2,000.

Note: The antibody has also been used successfully for Western blot but results may vary from lab to lab. The usefulness of the antibody for Western blot must be determined by each individual laboratory.

Optimal working dilutions must be determined by end user.
Biological Information
ImmunogenA synthetic peptide from human synphilin-1 (amino acids 829-847).
Epitopea.a. 829-847
HostRabbit
SpecificitySynphilin-1. Immunohistochemical analysis of human brain indicates a high level of specificity. Peptide sequence used shows 88% sequence homology with mouse synphilin-1 but mouse has not been tested for reactivity.
Species Reactivity
  • Human
  • Rat
Antibody TypePolyclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene encodes a protein containing several protein-protein interaction domains, including ankyrin-like repeats, a coiled-coil domain, and an ATP/GTP-binding motif. The encoded protein interacts with alpha-synuclein in neuronal tissue and may play a role in the formation of cytoplasmic inclusions and neurodegeneration. A mutation in this gene has been associated with Parkinson's disease. Alternatively spliced transcript variants encoding different isoforms of this gene have been described, but their full-length nature has yet to be determined.
Gene Symbol
  • SNCAIP
  • MGC39814
  • synphilin-1
  • SYPH1
  • Synphilin-1
UniProt Number
UniProt SummarySIZE: 919 amino acids; 100381 Da
SUBUNIT: Associates with SNCA, RNF19A AND PARK2.
TISSUE SPECIFICITY: Widely expressed, with highest levels in brain, heart and placenta.
PTM: Ubiquitinated; mediated by SIAH1 or RNF19A and leading to its subsequent proteasomal degradation.
DISEASE: SwissProt: Q9Y6H5 # Defects in SNCAIP are a cause of Parkinson disease (PD) [MIM:168600]. PD is a complex, multifactorial disorder that typically manifests after the age of 50 years, although early- onset cases (before 50 years) are known. PD generally arises as a sporadic condition but is occasionally inherited as a simple mendelian trait. Although sporadic and familial PD are very similar, inherited forms of the disease usually begin at earlier ages and are associated with atypical clinical features. PD is characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain.
SIMILARITY: SwissProt: Q9Y6H5 ## Contains 6 ANK repeats.
MISCELLANEOUS: Constructs encoding portions of SNCA and SNCAIP co- transfected in mammalian cells promote cytosolic inclusions resembling the Lewy bodies of Parkinson disease. Coexpression of SNCA, SNCAIP, and PARK2 result in the formation of Lewy body-like ubiquitin-positive cytosolic inclusions. Familial mutations in PARK2 disrupt the ubiquitination of SNCAIP and the formation of the ubiquitin-positive inclusions. These results provide a molecular basis for the ubiquitination of Lewy body-associated proteins and link PARK2 and SNCA in a common pathogenic mechanism through their interaction with SNCAIP.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain lyophilized material at -20°C to -70°C for up to 6 months. After reconstitution maintain frozen at -20°C in undiluted aliquots for up to 6 months. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size50 µL
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Número de referencia GTIN
AB5388 04053252677113

Documentation

Anti-Synphilin-1 Antibody, a.a. 829-847 Ficha datos de seguridad (MSDS)

Título

Ficha técnica de seguridad del material (MSDS) 

Anti-Synphilin-1 Antibody, a.a. 829-847 Certificados de análisis

CargoNúmero de lote
RABBIT ANTI-SYNPHILIN-1 POLYCLONAL ANTIBODY 3101027
RABBIT ANTI-SYNPHILIN-1 POLYCLONAL ANTIBODY -2662382 2662382

Referencias bibliográficas

Visión general referenciasPub Med ID
Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
Trimmer, Patricia A, et al.
J. Neurochem., 88: 800-12 (2004)  2004

Mostrar resumen
14756800 14756800